The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Vaccine-associated hypersensitivity
Open accessAbstract
INFORMATION FOR CATEGORY 1 CME CREDIT Credit can now be obtained, free for a limited time, by reading the review articles in this issue. Please note the following instructions. Method of Physician Participation in Learning Process: The core material for these activities can be read in this issue of the Journal or online at the JACI Web site: www.jacionline.org. The accompanying tests may only be submitted online at www.jacionline.org. Fax or other copies will not be accepted. Date of Original Release: February 2018. Credit may be obtained for these courses until January 31, 2019. Copyright Statement: Copyright © 2018‐2019. All rights reserved. Overall Purpose/Goal: To provide excellent reviews on key aspects of allergic disease to those who research, treat, or manage allergic disease. Target Audience: Physicians and researchers within the field of allergic disease. Accreditation/Provider Statements and Credit Designation: The American Academy of Allergy, Asthma & Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AAAAI designates this journal‐based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. List of Design Committee Members: Michael M. McNeil, MD, MPH, and Frank DeStefano, MD, MPH (authors); Zuhair K. Ballas, MD (editor) Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations: The authors declare that they have no relevant conflicts of interest. Z. K. Ballas (editor) disclosed no relevant financial relationships. Activity Objectives:To be able to discuss the differences in underlying mechanisms and presentation of immediate and delayed vaccine reactions.To be aware of the most recent vaccine guidelines regarding patients with egg allergy and influenza vaccination.To understand the limited data supporting other components of vaccines that might be implicated as possible causes of anaphylaxis.To be able to discuss the rate and clinical risk factors for vaccine‐triggered anaphylaxis. Recognition of Commercial Support: This CME activity has not received external commercial support. List of CME Exam Authors: Daniel Har, MD, Shyam Joshi, MD, Mariam Wahidi, MD, Shazia Lutfeali, MD, and David A. Khan, MD. Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations: The exam authors disclosed no relevant financial relationships. Vaccine‐associated hypersensitivity reactions are not infrequent; however, serious acute‐onset, presumably IgE‐mediated or IgG and complement‐mediated anaphylactic or serious delayed‐onset T cell–mediated systemic reactions are considered extremely rare. Hypersensitivity can occur because of either the active vaccine component (antigen) or one of the other components. Postvaccination acute‐onset hypersensitivity reactions include self‐limited localized adverse events and, rarely, systemic reactions ranging from urticaria/angioedema to full‐blown anaphylaxis with multisystem involvement. Risk of anaphylaxis after all vaccines is estimated to be 1.31 (95% CI, 0.90‐1.84) per million vaccine doses, respectively. Serious hypersensitivity reactions after influenza vaccines are particularly important because of the large number of persons vaccinated annually. Influenza vaccines are unique in requiring annual changes in the vaccines' antigenic composition to match the predicted circulating influenza strains. Recently, novel influenza vaccine types were introduced in the United States (recombinant vaccines, some with higher antigen content and a new adjuvanted vaccine). Providers should be aware of changing recommendations on the basis of recent published evidence for persons with a history of egg allergy to receive annual influenza vaccination. Further research is needed to elucidate the pathophysiology and risk factors for reported vaccine‐associated adverse events. Further research is also needed to determine whether repeated annual inactivated influenza vaccination, the number of vaccine antigens administered at the same time, and the current timing of routine infant vaccinations are optimal for overall population well‐being.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Beasley, R. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,389
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
The Xs and Y of immune responses to viral vaccines
Klein, S. L., Jedlicka, A., & Pekosz, A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70049-9 · Cited by 815
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
Commins, S. P., Satinover, S. M., Hosen, J., Mozena, J., Borish, L., Lewis, B. D., Woodfolk, J. A., & Platts-Mills, T. A. E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.052 · Cited by 690
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & DeStefano, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 608
Self-citation2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
Simons, F. E. R., Ebisawa, M., Sanchez-Borges, M., Thong, B. Y., Worm, M., Tanno, L. K., Lockey, R. F., El-Gamal, Y. M., Brown, S. G., Park, H.-S., et al. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0080-1 · Cited by 594
Anaphylaxis—a practice parameter update 2015
Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474
Romagnani, S. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01925.x · Cited by 431
Decker, W. W., Campbell, R. L., Manivannan, V., Luke, A., St. Sauver, J. L., Weaver, A., Bellolio, M. F., Bergstralh, E. J., Stead, L. G., & Li, J. T. C. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.043 · Cited by 410
Pennell, L. M., Galligan, C. L., & Fish, E. N. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.013 · Cited by 404
Zhou, W., Pool, V., Iskander, J. K., English-Bullard, R., Ball, R., Wise, R. P., Haber, P., Pless, R., Mootrey, G. T., Ellenberg, S. S., et al. (2003) · PubMed · Cited by 400
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Bresee, J. S., Fry, A. M., & Jernigan, D. B. (2017) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6602a1 · Cited by 387
Rüggeberg, J. U., Gold, M. S., Bayas, J.-M., Blum, M. D., Bonhoeffer, J., Friedlander, S., de Souza Brito, G., Heininger, U., Imoukhuede, B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383
Risk of anaphylaxis after vaccination in children and adults.
McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., Hambidge, S. J., Lee, G. M., Jackson, L. A., Irving, S. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.048 · Cited by 381
Self-citationSex hormones as immunomodulators in health and disease
Verthelyi, D. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00044-3 · Cited by 380
Gender difference, sex hormones, and immediate type hypersensitivity reactions
Chen, W., Mempel, M., Schober, W., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01880.x · Cited by 370
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Bresee, J. S., Fry, A. M., & Jernigan, D. B. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14511 · Cited by 327
Risk of anaphylaxis after vaccination of children and adolescents.
Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team (2003) · PEDIATRICS · doi:10.1542/peds.112.4.815 · Cited by 320
Self-citationSexual dimorphism of humoral immunity with human vaccines
Cook, I. F. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.054 · Cited by 320
Engler, R. J. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.513 · Cited by 320
Human T cell immunosenescence and inflammation in aging
Bektas, A., Schurman, S. H., Sen, R., & Ferrucci, L. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0716-335r · Cited by 271
Grohskopf, L. A., Olsen, S. J., Sokolow, L. Z., Bresee, J. S., Cox, N. J., Broder, K. R., Karron, R. A., & Walter, E. B. (2014) · American Journal of Transplantation · doi:10.1111/ajt.13065 · Cited by 262
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
McNeil, M. M., Gee, J., Weintraub, E. S., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R., Naleway, A. L., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.073 · Cited by 247
Self-citationAnaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
Kelso, J. M., Jones, R. T., & Yunginger, J. W. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90344-f · Cited by 246
González-Pérez, A., Aponte, Z., Vidaurre, C. F., & Rodríguez, L. A. G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.009 · Cited by 204
International Consensus (ICON): allergic reactions to vaccines
Dreskin, S. C., Halsey, N. A., Kelso, J. M., Wood, R. A., Hummell, D. S., Edwards, K. M., Caubet, J.-C., Engler, R. J. M., Gold, M. S., Ponvert, C., et al. (2016) · World Allergy Organization Journal · doi:10.1186/s40413-016-0120-5 · Cited by 195
Nichol, K. L. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440130090009 · Cited by 194
The hygiene hypothesis: current perspectives and future therapies
Stiemsma, L., Reynolds, L., Turvey, S., & Finlay, B. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s61528 · Cited by 190
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., O'Hagan, D. T., & Podda, A. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d6394 · Cited by 190
Pellegrini, M., Nicolay, U., Lindert, K., Groth, N., & Della Cioppa, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.101 · Cited by 183
Wodi, A. P., Ault, K., Hunter, P., McNally, V., Szilagyi, P. G., & Bernstein, H. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7006a1 · Cited by 175
The hygiene hypothesis in allergy and asthma: an update
Brooks, C., Pearce, N., & Douwes, J. (2013) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32835ad0d2 · Cited by 169
Urticaria and Angioedema: an Update on Classification and Pathogenesis
Radonjic-Hoesli, S., Hofmeier, K. S., Micaletto, S., Schmid-Grendelmeier, P., Bircher, A., & Simon, D. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8628-1 · Cited by 167
Early life factors that affect allergy development
Reynolds, L. A., & Finlay, B. B. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.39 · Cited by 156
Vaccination and allergy: EAACI position paper, practical aspects
Nilsson, L. J., Brockow, K., Alm, J. S., Cardona, V., Caubet, J., Gomes, E. R., Jenmalm, M. C., Lau, S., Netterlid, E., Schwarze, J., et al. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12762 · Cited by 156
Keet, C. A., Savage, J. H., Seopaul, S., Peng, R. D., Wood, R. A., & Matsui, E. C. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.12.007 · Cited by 154
Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years)
Simons, F. E. R., & Sampson, H. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.014 · Cited by 146
Pool, V., Braun, M. M., Kelso, J. M., Mootrey, G. T., Chen, R. T., Yunginger, J. W., Jacobson, R. M., Gargiullo, P. M., & the VAERS Team (2002) · PEDIATRICS · doi:10.1542/peds.110.6.e71 · Cited by 135
Anaphylaxis following quadrivalent human papillomavirus vaccination
Brotherton, J. M. L., Gold, M., Kemp, A. S., McIntyre, P. B., Burgess, M. A., Campbell‐Lloyd, S., & Panel, O. B. O. T. N. S. W. H. H. A. E. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080916 · Cited by 128
Anaphylaxis from yellow fever vaccine
Kelso, J. M., Mootrey, G. T., & Tsai, T. F. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70245-9 · Cited by 125
Clark, S., Wei, W., Rudders, S. A., & Camargo, C. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.018 · Cited by 121
Hox, V., Desai, A., Bandara, G., Gilfillan, A. M., Metcalfe, D. D., & Olivera, A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.003 · Cited by 108
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
Tsai, T. F. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.2.159 · Cited by 107 · cited 3×
“Fluad was approved and recommended for use in adults aged 65 years and older starting in the 2016-2017 influenza season.18 Fluad is manufactured by using an egg-based process and is formulated with the adjuvant MF59.”
BackgroundInfluentialAnaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow’s milk allergy
Kattan, J. D., Konstantinou, G. Ν., Cox, A. L., Nowak-Wegrzyn, A. H., Giménez, G., Sampson, H. A., & Sicherer, S. H. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.046 · Cited by 96
Immune deviation and the hygiene hypothesis: A review of the epidemiological evidence
Kemp, A. H., & Björkstén, B. (2003) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2003.00017.x · Cited by 96
DiMiceli, L. E., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander, J., & V.A.E.R.S. Team (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.069 · Cited by 93
Sex differences in injection site reactions with human vaccines
Cook, I. F. (2009) · Human Vaccines · doi:10.4161/hv.8476 · Cited by 87
Robinson, C. L., Romero, J. R., Kempe, A., & Pellegrini, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6605e1 · Cited by 87
Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism
Stone, C. A., Hemler, J. A., Commins, S. P., Schuyler, A. J., Phillips, E. J., Peebles, R. S., & Fahrenholz, J. M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.037 · Cited by 85
Recommendations for Prevention and Control of Influenza in Children, 2017 – 2018
Byington, C. L., Maldonado, Y., Barnett, E. D., Campbell, J. D., Davies, H. D., Edwards, K. M., Lynfield, R., Muñoz, F. M., Nolt, D. L., Nyquist, A., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-2550 · Cited by 68
Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine
Benjamin, C. M., Chew, G. C., & Silman, A. J. (1992) · BMJ · doi:10.1136/bmj.304.6834.1075 · Cited by 63
Caubet, J., & Ponvert, C. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.04.004 · Cited by 58
Nolan, T. M., Bravo, L. C., Ceballos, A., Mitha, E., Gray, G., Quiambao, B. P., Patel, S. S., Bizjajeva, S., Bock, H. L., Bermal, N., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.068 · Cited by 56
Miliauskas, J. R., Mukherjee, T. M., & Dixon, B. (1993) · PubMed · Cited by 55
Dissecting the indirect effects caused by vaccines into the basic elements
Lefebvre, C. D. S., Terlinden, A., & Standaert, B. A. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1052196 · Cited by 53
Russell, M. L., Pool, V., Kelso, J. M., & Tomazic‐Jezic, V. J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.042 · Cited by 53
Postimmunization (Vaccination) Injection-Site Reactions
Miliauskas, J. R., Mukherjee, T. M., & Dixon, B. R. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199305000-00012 · Cited by 53
Anaphylaxis as an adverse event following immunisation in the UK and Ireland
Erlewyn‐Lajeunesse, M., Hunt, L. P., Heath, P. T., & Finn, A. H. R. (2012) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-301163 · Cited by 45
Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature
Leventhal, J. S., Berger, E. M., Brauer, J. A., & Cohen, D. E. (2012) · Dermatitis · doi:10.1097/der.0b013e31825228cf · Cited by 45
Glanz, J. M., Newcomer, S. R., Hambidge, S. J., Daley, M. F., Narwaney, K. J., Xu, S., Lee, G. M., Baggs, J., Klein, N. P., Nordin, J. D., et al. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.112 · Cited by 43
Rouleau, I., Serres, G. D., Drolet, J. P., Skowronski, D. M., Ouakki, M., Toth, E., Landry, M., Ménard, S., & Gagnon, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.033 · Cited by 40
Generalized eczema in an 18‐month‐old boy due to phenoxyethanol in DPT vaccine
VOGT, T. M., Landthaler, M., & Stolz, W. (1998) · Contact Dermatitis · doi:10.1111/j.1600-0536.1998.tb05644.x · Cited by 39
Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age
Kiraly, N. J., Koplin, J. J., Crawford, N. W., Bannister, S., Flanagan, K. L., Holt, P. G., Gurrin, L. C., Lowe, A. J., Tang, M. L. K., Wake, M. A., et al. (2015) · Allergy · doi:10.1111/all.12830 · Cited by 38
Lauren, C. T., Belsito, D. V., Morel, K. D., & LaRussa, P. S. (2016) · PEDIATRICS · doi:10.1542/peds.2014-1690 · Cited by 36
Zudaire, L. E., del Castillo, L. O., Alonso‐Lebrero, E., García, F. J. Á., Álvarez, N. C., García-Sánchez, N., & Martorell‐Aragonés, A. (2015) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2015.01.004 · Cited by 33
Cheng, D. R., Perrett, K. P., Choo, S., Danchin, M. H., Buttery, J. P., & Crawford, N. W. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.008 · Cited by 32
Erlewyn‐Lajeunesse, M., Dymond, S., Slade, I., Mansfield, H. L., Fish, R., Jones, O., & Benger, J. R. (2009) · Drug Safety · doi:10.2165/11318970-000000000-00000 · Cited by 28
Effect of gender on reporting of MMR adverse events in Saudi Arabia
Khalil, M. K. M., Mazrou, Y. Y. A., Ghamdi, Y. S. A., Tumsah, S., Jeffri, M. A., & Meshkhas, A. (2003) · Eastern Mediterranean Health Journal · doi:10.26719/2003.9.1-2.152 · Cited by 22
Vaccinations in the first year of life and risk of atopic disease – Results from the KiGGS study
Schlaud, M., Schmitz, R., Poethko‐Müller, C., & Kuhnert, R. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.111 · Cited by 22
Rouleau, I., Serres, G. D., Skowronski, D. M., Drolet, J. P., Lemire, C., Toth, E., & Landry, M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.059 · Cited by 16
Anaphylaxis following H1N1 pandemic vaccines: Safety data in perspective
Silva, F. T. D., Delaigle, A., Slavin, D., Bauchau, V., Fries, L. F., & Seifert, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.026 · Cited by 16
Zafack, J. G., Serres, G. D., Rouleau, I., Gariépy, M.-C., Gagnon, R., Drolet, J., & Skowronski, D. M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.09.048 · Cited by 15
Does anaphylaxis masquerade as asthma in children?
Sargant, N. N., Erlewyn‐Lajeunesse, M., & Benger, J. R. (2014) · Emergency Medicine Journal · doi:10.1136/emermed-2014-203603 · Cited by 13
Cited by
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e1 · Cited by 479
Shimabukuro, T. T., Cole, M., & Su, J. R. (2021) · JAMA · doi:10.1001/jama.2021.1967 · Cited by 475
Shimabukuro, T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 325
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 269
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s315727 · Cited by 253
Metadata
- Authors
- McNeil, M. M., & DeStefano, F.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 141
- Issue
- 2
- Pages
- 463-472
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2787221426
- Cited by
- 273
- References
- 78
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.